{"nctId":"NCT00106028","briefTitle":"Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children","startDateStruct":{"date":"2004-11"},"conditions":["Osteogenesis Imperfecta"],"count":143,"armGroups":[{"label":"Placebo Daily","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Risedronate Daily","type":"EXPERIMENTAL","interventionNames":["Drug: risedronate sodium (Actonel)"]}],"interventions":[{"name":"risedronate sodium (Actonel)","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* OI diagnosis\n* increased risk of fracture: either has a history of at least 1 radiographically confirmed, non-traumatic or low impact fracture plus low bone mineral density (BMD) or has very low BMD with or without a history of fractures.\n\nExclusion Criteria:\n\n* Any bisphosphonate use within one year of enrollment","healthyVolunteers":false,"sex":"ALL","minimumAge":"4 Years","maximumAge":"15 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"SECONDARY","title":"Percent Change From Baseline Lumbar Spine Bone Mineral Density (BMD) at Month 24, ITT Population","description":"Lumbar Spine Bone Mineral Density (BMD) measured by dual-energy x-ray absorptiometry (DXA)and read by central reader.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.316","spread":null},{"groupId":"OG001","value":"25.754","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline Lumbar Spine Bone Mineral Density (BMD) at Month 36, ITT Population","description":"Lumbar Spine Bone Mineral Density (BMD) measured by dual-energy x-ray absorptiometry (DXA)and read by central reader.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"33.216","spread":null},{"groupId":"OG001","value":"34.753","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMD at Month 12, ITT Population","description":"Percent Change from baseline in Total Body Bone Mineral Density (BMD) measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.252","spread":null},{"groupId":"OG001","value":"5.806","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMD at Month 24, ITT Population","description":"Percent Change from baseline in Total Body Bone Mineral Density (BMD) measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.716","spread":null},{"groupId":"OG001","value":"10.214","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMD at Month 36, ITT Population","description":"Percent Change from baseline in Total Body Bone Mineral Density (BMD) measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.540","spread":null},{"groupId":"OG001","value":"13.076","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMC (Bone Mineral Content) at Month 12, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.885","spread":null},{"groupId":"OG001","value":"28.218","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMC (Bone Mineral Content) at Month 24, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.367","spread":null},{"groupId":"OG001","value":"48.407","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine BMC (Bone Mineral Content) at Month 36, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"68.054","spread":null},{"groupId":"OG001","value":"68.333","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMC at Month 12, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.483","spread":null},{"groupId":"OG001","value":"21.977","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMC at Month 24, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"36.465","spread":null},{"groupId":"OG001","value":"37.938","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body BMC at Month 36, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56.211","spread":null},{"groupId":"OG001","value":"56.526","spread":null}]}]}]},{"type":"SECONDARY","title":"Lumbar Spine Z-score - Percent Change From Baseline to Month 12, ITT Population","description":"Lumbar Spine Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.028","spread":null},{"groupId":"OG001","value":"25.648","spread":null}]}]}]},{"type":"SECONDARY","title":"Lumbar Spine Z-score - Percent Change From Baseline to Month 24, ITT Population","description":"Lumbar Spine Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.608","spread":null},{"groupId":"OG001","value":"29.637","spread":null}]}]}]},{"type":"PRIMARY","title":"Percent Change From Baseline Lumbar Spine Bone Mineral Density (BMD) at Month 12, ITT Population","description":"Lumbar Spine Bone Mineral Density (BMD) measured by dual-energy x-ray absorptiometry (DXA)and read by central reader. Duplicate scans obtained at screening and Month 12.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.592","spread":null},{"groupId":"OG001","value":"16.159","spread":null}]}]}]},{"type":"SECONDARY","title":"Lumbar Spine Z-score - Percent Change From Baseline to Month 36, ITT Population","description":"Lumbar Spine Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.325","spread":null},{"groupId":"OG001","value":"25.640","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Body Z-score- Percent Change From Baseline to Month 12, ITT Population","description":"Total Body Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.661","spread":null},{"groupId":"OG001","value":"16.933","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Body Z-score- Percent Change From Baseline to Month 24, ITT Population","description":"Total Body Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.371","spread":null},{"groupId":"OG001","value":"7.879","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Body Z-score- Percent Change From Baseline to Month 36, ITT Population","description":"Total Body Z-score - number of standard deviations a patient's BMD differs from the average BMD of their age, sex, and ethnicity. Positive scores indicate BMD above the mean; Positive values are \"best values\" and negative values are \"worst values\".","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.146","spread":null},{"groupId":"OG001","value":"-1.494","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine Bone Area at Month 12, ITT Population","description":"Measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.803","spread":null},{"groupId":"OG001","value":"9.817","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine Bone Area at Month 24, ITT Population","description":"Measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.381","spread":null},{"groupId":"OG001","value":"17.266","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Lumbar Spine Bone Area at Month 36, ITT Population","description":"Measured by DXA.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.952","spread":null},{"groupId":"OG001","value":"23.292","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body Bone Area Month 12, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.405","spread":null},{"groupId":"OG001","value":"14.939","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body Bone Area Month 24, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.051","spread":null},{"groupId":"OG001","value":"25.116","spread":null}]}]}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Total Body Bone Area Month 36, ITT Population","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"37.109","spread":null},{"groupId":"OG001","value":"38.303","spread":null}]}]}]},{"type":"SECONDARY","title":"New Morphometric Vertebral Fracture at Month 12, ITT Population","description":"Morphometric Vertebral Fracture measured by semi-quantitative (SQ) analysis of x-rays using the Genant scoring system at endpoint. (Ref: Genant 1993). SQ-Scores range from 0 (no fracture) to 3 (severe fracture). New fracture = SQ score is 0 at baseline and \\>0 at the specified end visit.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"60","spread":null}]}]}]},{"type":"SECONDARY","title":"New Morphometric Vertebral Fracture at Month 36, ITT Population","description":"Morphometric Vertebral Fracture measured by SQ analysis of x-rays using the Genant scoring system. (Ref: Genant 1993). SQ-Scores range from 0 (no fracture) to 3 (severe fracture). New fracture = SQ score is 0 at baseline and \\>0 at the specified end visit.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]}]},{"type":"SECONDARY","title":"Categorization by Number of New Morphometric Vertebral Fracture at Month 12, ITT","description":"Patients with 1 or more New Morphometric Vertebral Fracture as measured by SQ analysis of x-rays using the Genant scoring system (Ref: Genant 1993). SQ-Scores range from 0 (no fracture) to 3 (severe fracture). Incidence = SQ score is 0 at baseline and \\>0 at post-baseline.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"60","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Categorization by Number of New Morphometric Vertebral Fracture at Month 36, ITT","description":"Patients with 1 or more New Morphometric Vertebral Fracture as measured by SQ analysis of x-rays using the Genant scoring system (Ref: Genant 1993). SQ-Scores range from 0 (no fracture) to 3 (severe fracture). Incidence = SQ score is 0 at baseline and \\>0 at post-baseline.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence New Vertebral Fractures by SQ (Semi-Quantitative) Score, Patients Aged 4-9 Years, Month 12, ITT Population","description":"Patients aged 4-9 years with new morphometric vertebral fractures as measured by SQ analysis of x-rays using the Genant scoring system at Month 12 +/- 14 days. (Ref: Genant 1993). SQ Score mild - 0/no fracture to Grade 1, Moderate to Severe - change from 0/no fracture to Grade 2-3.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"19","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence New Vertebral Fractures by SQ Score, Patients Aged 10-15 Years, Month 12, ITT Population","description":"Patients aged 10-15 years with new morphometric vertebral fractures as measured by SQ analysis of x-rays using the Genant scoring system at Month 12 +/- 14 days. (Ref: Genant 1993). SQ Score mild - 0/no fracture to Grade 1, Moderate to Severe - change from 0/no fracture to Grade 2-3.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Probability of Fracture in 12 Months (Kaplan-Meier Cumulative Incidence), ITT Population","description":"Long bones include radius, ulna, humerus, tibia, fibula, femur, upper limb and lower limb fracture.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":"29"},{"groupId":"OG001","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5043","spread":".0740"},{"groupId":"OG001","value":"0.314","spread":".0484"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":"0"},{"groupId":"OG001","value":"0","spread":"0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.5043","spread":"0.0740"},{"groupId":"OG001","value":"0.314","spread":"0.0484"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.3618","spread":"0.0714"},{"groupId":"OG001","value":"0.1954","spread":"0.0413"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.204","spread":"0.0576"},{"groupId":"OG001","value":"0.1311","spread":"0.0353"}]}]}]},{"type":"SECONDARY","title":"Number of Clinical Fractures, Month 12, ITT Population","description":"Long bones include radius, ulna, humerus, tibia, fibula, femur, upper limb and lower limb fracture.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"29","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"18","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum BAP - Percent Change From Baseline to Month 12, ITT Population","description":"Serum Bone Alkaline Phosphatase (BAP - bone formation marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.783","spread":null},{"groupId":"OG001","value":"-4.895","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum BAP - Percent Change From Baseline to Month 24, ITT Population","description":"Serum Bone Alkaline Phosphatase (BAP - bone formation marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-11.196","spread":null},{"groupId":"OG001","value":"-11.128","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum BAP - Percent Change From Baseline to Month 36, ITT Population","description":"Serum Bone Alkaline Phosphatase (BAP - bone formation marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-19.884","spread":null},{"groupId":"OG001","value":"-24.570","spread":null}]}]}]},{"type":"SECONDARY","title":"Urine NTX/Cr - Percent Change From Baseline at Month 12, ITT Population","description":"Urine type-I collagen N-telopeptide/creatinine (NTX/Cr; bone resorption marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-14.556","spread":null},{"groupId":"OG001","value":"-41.185","spread":null}]}]}]},{"type":"SECONDARY","title":"Urine NTX/Cr - Percent Change From Baseline at Month 24, ITT Population","description":"Urine type-I collagen N-telopeptide/creatinine (NTX/Cr; bone resorption marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-40.358","spread":null},{"groupId":"OG001","value":"-31.318","spread":null}]}]}]},{"type":"SECONDARY","title":"Urine NTX/Cr - Percent Change From Baseline at Month 36, ITT Population","description":"Urine type-I collagen N-telopeptide/creatinine (NTX/Cr; bone resorption marker). Negative percent changes indicate response to treatment.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-47.570","spread":null},{"groupId":"OG001","value":"-52.609","spread":null}]}]}]},{"type":"SECONDARY","title":"Wong-Baker FACES Pain Rating Scale - Change From Baseline to Month 12, ITT Population","description":"Wong-Baker FACES Pain Rating Scale (pain assessment scale using facial expressions, translated into a range from 0= no pain \\[smiling face\\] to 10= worst pain possible \\[distorted face with tears\\]; negative values indicate decrease in pain). Reference: Wong DL et al.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.056","spread":null},{"groupId":"OG001","value":"-0.409","spread":null}]}]}]},{"type":"SECONDARY","title":"Bone Age (Years), Change From Baseline to Month 12, ITT Population","description":"Bone Age determined by visual assessment of hand / wrist radiographs.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.956","spread":null},{"groupId":"OG001","value":"1.083","spread":null}]}]}]},{"type":"SECONDARY","title":"Bone Age (Years), Change From Baseline to Month 24, ITT Population","description":"Bone Age determined by visual assessment of hand / wrist radiographs.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.147","spread":null},{"groupId":"OG001","value":"2.155","spread":null}]}]}]},{"type":"SECONDARY","title":"Bone Age (Years), Change From Baseline to Month 36, ITT Population","description":"Bone Age determined by visual assessment of hand / wrist radiographs.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.087","spread":null},{"groupId":"OG001","value":"3.096","spread":null}]}]}]},{"type":"SECONDARY","title":"Annualized Growth Velocity - Change From Baseline to Month 12, ITT Population","description":"Annualized Growth Velocity \\[= bone age change from baseline x (365.25/time in days between baseline and the bone age measurement)\\]","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.895","spread":null},{"groupId":"OG001","value":"1.002","spread":null}]}]}]},{"type":"SECONDARY","title":"Annualized Growth Velocity - Change From Baseline to Month 36, ITT Population","description":"Annualized Growth Velocity \\[= bone age change from baseline x (365.25/time in days between baseline and the bone age measurement)\\]","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.982","spread":null},{"groupId":"OG001","value":"1.011","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":49},"commonTop":["Fall","Pain in extremity","Back pain","Headache","Hand fracture"]}}}